News & Updates
Filter by Specialty:
Show Multimedia Only
Tofacitinib may promote HBV reactivation in certain RA patients
24 Sep 2021
Use of tofacitinib for rheumatoid arthritis (RA) may lead to reactivation of hepatitis B virus (HBV), especially among hepatitis B surface antigen-positive (HBsAg+) and HBsAg-negative/hepatitis B core antibody-positive (HBsAg–/HBcAb+) patients, according to a study from Taiwan.
Tofacitinib may promote HBV reactivation in certain RA patients
24 Sep 2021
Continuous glucose monitoring: The next frontier in diabetes self-monitoring
24 Sep 2021
byProfessor Dr Chan Siew Pheng, Senior Consultant Endocrinologist, President of Malaysian Endocrine and Metabolic Society (MEMS)
One of the fastest-growing health crises facing our nation is the widely discussed chronic noncommunicable disease (NCD) known as diabetes.
Continuous glucose monitoring: The next frontier in diabetes self-monitoring
24 Sep 2021
MV130 immunotherapy prevents COPD exacerbations
24 Sep 2021
byElaine Soliven
Treatment with MV130, a sublingual bacterial immunotherapy, reduces the number of exacerbations in patients with chronic obstructive pulmonary disease (COPD), according to a recent study presented at ERS 2021.
